Glenmark Pharmaceuticals
GLENMARK.NS
$12.67
Share price
-1.30%
Change (1 day)
83.89%
Change (1 year)
Categories
Glenmark Pharmaceuticals (GLENMARK.NS) - Total debt
Total debt on the balance sheet as of September 2023 : $0.62 B
According to Glenmark Pharmaceuticals 's latest financial reports the company's total debt is $0.62 B. A company’s total debt is the sum of all current and non-current debts.
Glenmark Pharmaceuticals - Total debt on balance sheet (from 2012 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-03-31 | $0.56 B | 7.87% |
| 2022-03-31 | $0.52 B | -23.03% |
| 2021-03-31 | $0.67 B | -1.3% |
| 2020-03-31 | $0.68 B | 7.34% |
| 2019-03-31 | $0.64 B | -10.08% |
| 2018-03-31 | $0.71 B | -2.26% |
| 2017-03-31 | $0.72 B | 21.33% |
| 2016-03-31 | $0.60 B | -1.15% |
| 2015-03-31 | $0.60 B | 11.35% |
| 2014-03-31 | $0.54 B | 7.18% |
| 2013-03-31 | $0.50 B | 15.45% |
| 2012-03-31 | $0.44 B | -6.64% |
| 2011-03-31 | $0.47 B | 13.27% |
| 2010-03-31 | $0.41 B | 1.18% |
| 2009-03-31 | $0.41 B | 66.01% |
| 2008-03-31 | $0.24 B | 14.5% |
| 2007-03-31 | $0.21 B | 31.37% |
| 2006-03-31 | $0.16 B | 64.64% |
| 2005-03-31 | $0.10 B | 278.42% |
| 2004-03-31 | $26.5 M |